We are live on
!
Find out more
Natixis Advisors Portfolio holdings
AUM
$71.9B
1-Year Est. Return
28.03%
This Fund
S&P 500
This Quarter
Est. Return
-3.85%
1 Year Est. Return
+28.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+131.42%
10 Year Est. Return
+475.22%
AUM
$23.6B
AUM Growth
+$900M
(+4%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
7.66%
Top 10 Holdings %
Top 10 Hldgs %
15.31%
Holding
1,542
New
90
Increased
818
Reduced
532
Closed
102
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$149M |
| 2 |
Apple
AAPL
|
+$102M |
| 3 |
Amazon
AMZN
|
+$85.4M |
| 4 |
Vanguard Morningstar Value ETF
VTV
|
+$67.1M |
| 5 |
Microsoft
MSFT
|
+$51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$31.5M |
| 2 |
Nutrien
NTR
|
+$29.5M |
| 3 |
AT&T
T
|
+$28.9M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$27.6M |
| 5 |
Sanofi
SNY
|
+$27.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.61% |
| 2 | Healthcare | 14.15% |
| 3 | Financials | 13.71% |
| 4 | Consumer Discretionary | 9.67% |
| 5 | Industrials | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
OFG Bancorp
OFG
$2.21B
| $759K | ﹤0.01% |
30,186
-1,011
| -3% | -$27.4K |
|
1177
Pembina Pipeline
PBA
$29.3B
| $758K | ﹤0.01% |
24,972
+1,507
| +6% | +$53.7K |
|
1178
Clarivate
CLVT
$1.38B
| $755K | ﹤0.01% |
80,401
-805,450
| -91% | -$10.2M |
|
1179
Ameresco
AMRC
$980M
| $740K | ﹤0.01% |
+11,128
| New | +$683K |
|
|
CIVI
1180
DELISTED
Civitas Resources
CIVI
| $739K | ﹤0.01% |
12,883
+78
| +0.6% | +$4.59K |
|
1181
ORIX
IX
$42.7B
| $735K | ﹤0.01% |
52,005
-91,620
| -64% | -$1.5M |
|
|
ONT
1182
Onterris Inc
ONT
$731M
| $732K | ﹤0.01% |
21,765
+4,870
| +29% | +$193K |
|
1183
Gentherm
THRM
$1.32B
| $731K | ﹤0.01% |
14,701
-605
| -4% | -$36.6K |
|
1184
Boot Barn
BOOT
$4.58B
| $727K | ﹤0.01% |
12,438
+770
| +7% | +$51.6K |
|
1185
Interactive Brokers
IBKR
$38.4B
| $727K | ﹤0.01% |
+45,512
| New | +$701K |
|
1186
James Hardie Industries
JHX
$15.2B
| $720K | ﹤0.01% |
36,383
+8,176
| +29% | +$191K |
|
|
SJI
1187
DELISTED
South Jersey Industries, Inc.
SJI
| $716K | ﹤0.01% |
21,418
+1,433
| +7% | +$48.9K |
|
1188
Arrowhead Research
ARWR
$12.1B
| $706K | ﹤0.01% |
21,353
+1,589
| +8% | +$64.1K |
|
1189
Wayfair
W
$11.8B
| $703K | ﹤0.01% |
21,609
+11,122
| +106% | +$588K |
|
1190
Ionis Pharmaceuticals
IONS
$8.93B
| $700K | ﹤0.01% |
15,818
-12
| -0.1% | -$506 |
|
1191
MDU Resources
MDU
$4.18B
| $700K | ﹤0.01% |
67,296
+12,886
| +24% | +$142K |
|
1192
Pinnacle West Capital
PNW
$12.4B
| $699K | ﹤0.01% |
+10,837
| New | +$798K |
|
1193
Archrock
AROC
$6.16B
| $697K | ﹤0.01% |
108,591
+54,486
| +101% | +$415K |
|
1194
Lumen
LUMN
$6.43B
| $696K | ﹤0.01% |
95,646
-82,473
| -46% | -$839K |
|
1195
Trip.com Group
TCOM
$29B
| $696K | ﹤0.01% |
25,480
-850
| -3% | -$22.3K |
|
|
MPT
1196
Medical Properties Trust
MPT
$2.84B
| $695K | ﹤0.01% |
58,565
-1,373
| -2% | -$20.8K |
|
1197
BrightView Holdings
BV
$1.24B
| $692K | ﹤0.01% |
87,160
-11,387
| -12% | -$122K |
|
1198
Unum
UNM
$13.2B
| $691K | ﹤0.01% |
17,811
+1,484
| +9% | +$54.3K |
|
|
TEF
1199
DELISTED
Telefonica
TEF
| $688K | ﹤0.01% |
212,363
-79,131
| -27% | -$335K |
|
1200
Power Integrations
POWI
$3.15B
| $687K | ﹤0.01% |
10,682
-16,519
| -61% | -$1.24M |
|
Similar funds
BC
CBU
Natixis Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Natixis Advisors held 1,542 positions worth $23.6B, up 4% from $22.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Natixis Advisors deployed $1.81B of net new capital in Q3 2022, opening 90 new positions and adding to 818 existing holdings. Its largest new stake was Chemed: 52,930 shares worth $23.1M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Vanguard Morningstar Total Stock Market ETF, an estimated $31.5M trimmed.
- Natixis Advisors's largest Q3 2022 buy was Chemed: 52,930 shares worth $23.1M.
- Natixis Advisors added most to Vanguard FTSE Developed Markets ETF in Q3 2022, an estimated $149M increase.
- Natixis Advisors's biggest Q3 2022 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $31.5M.
- Natixis Advisors fully exited Domino's in Q3 2022, selling an estimated $4.15M.
- Natixis Advisors's ten largest holdings make up 15% of its $23.6B portfolio in Q3 2022.
- Natixis Advisors opened 90 new positions and closed 102 in Q3 2022.
- Natixis Advisors's portfolio value rose 4% quarter-over-quarter to $23.6B.
Based on Natixis Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.